|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3B
|
|
pubmed:dateCreated |
2007-6-28
|
|
pubmed:abstractText |
To improve the prognosis of gallbladder cancer (GC) patients, a better understanding of the mechanisms of tumor development and progression is essential. The deregulation of cell cycle control is a critical step in the development of cancer. The purpose of this study was to investigate the expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in an unselected GC patient population and to assess the association of these markers with p27(Kip1) expression, p53 gene mutation status and clinical parameters of the patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1679-84
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17595796-Cyclin-Dependent Kinase Inhibitor p21,
pubmed-meshheading:17595796-Cyclin-Dependent Kinase Inhibitor p27,
pubmed-meshheading:17595796-Cyclin-Dependent Kinase Inhibitor p57,
pubmed-meshheading:17595796-Female,
pubmed-meshheading:17595796-Gallbladder Neoplasms,
pubmed-meshheading:17595796-Humans,
pubmed-meshheading:17595796-Male,
pubmed-meshheading:17595796-Middle Aged,
pubmed-meshheading:17595796-Mutation,
pubmed-meshheading:17595796-Paraffin Embedding,
pubmed-meshheading:17595796-Prognosis,
pubmed-meshheading:17595796-Receptor, erbB-2,
pubmed-meshheading:17595796-Survival,
pubmed-meshheading:17595796-Tumor Markers, Biological,
pubmed-meshheading:17595796-Tumor Suppressor Protein p53
|
|
pubmed:articleTitle |
Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
|
|
pubmed:affiliation |
Department of Surgery, Division of General Surgery, Medical University of Vienna, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article
|
